Lancet Oncology

The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide. The journal is now the world-leading clinical oncology periodical publishing high-quality, peer-reviewed research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academic centres). Content covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology. Much of the journal’s articles are published Online First for enhanced timeliness prior to print publication. Uniquely, all original research is peer-reviewed via a fast-track service, and successful papers are published within 8 weeks of submission. The journal also regularly features podcasts, video, infographics, and curated web content.

Publisher
Elsevier
Website
http://www.thelancet.com/journals/lanonc/issue/current
Impact factor
33.9 (2016)

Some content from Wikipedia, licensed under CC BY-SA

Oncology & Cancer

Clinical trial shows promising new treatment for rare blood cancer

Lymphoma is a type of blood cancer that develops from lymphocytes (a type of white blood cell). It has many subtypes. A rare subtype, called intravascular large B-cell lymphoma (or IVLBCL) is notably hard to diagnose accurately ...

Oncology & Cancer

Decline in cancer diagnoses due to corona crisis

Cancer care has dramatically changed as a result of the measures taken during the COVID-19 pandemic: Many patients have not been going to their GPs, or putting it off, and have been referred to the hospital later. Consequently, ...

Oncology & Cancer

High cost of cancer drugs not always justified

A growing number of new cancer drugs have come on the market in recent years, yet the cost of therapies in Europe and the United States have risen. This is driving up healthcare costs, which poses a challenge not only for ...

Medical research

Immunotherapy drug for advanced lung cancer shows promise

Lung cancer spreads to the brain in about one-quarter of patients with an advanced form of the disease. To date, radiation has been the only treatment option, but it comes with toxic side effects. Researchers at Yale Cancer ...

page 1 from 26